Autografting for patients with CML in chronic phase: an update. Hammersmith BMT Team LRF Centre for Adult Leukaemia.

Journal article

Between 1984 and 1992, 21 patients with chronic myeloid leukaemia (CML) in chronic phase (CP) were treated with high-dose chemotherapy (or chemoradiotherapy) followed by autografting with unmanipulated peripheral blood stem cells (PBSC). 12 of these patients survive at a median of 82 months from the time of autografting (range 9-105 months). Nine patients died, six of leukaemia in transformation and three from other causes. Survival of these 21 autograft patients was compared to that of 636 a...

Expand abstract

Authors: Hoyle, C; Gray, R; Goldman, J

• Publication status: Published
• Journal: British journal of haematology
• Volume: 86
• Issue: 1
• Pages: 76-81
• Publication date: 1994-01-01
• DOI: 10.1111/j.1365-2141.1994.tb03255.x
• EISSN: 1365-2141
• ISSN: 0007-1048
• Language: English
• Keywords: Female; Adult; Middle Aged; Prognosis; Male; Philadelphia Chromosome; Hematopoietic Stem Cell Transplantation; Cause of Death; Leukemia, Myeloid, Chronic-Phase; Combined Modality Therapy; Bone Marrow Transplantation; Transplantation, Autologous; Humans; Graft Survival